Barroso-Sousa, R. (2019) “TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)”, Mastology. Rio de Janeiro, 29(3), p. 5. Available at: https://revistamastology.emnuvens.com.br/revista/article/view/728 (Accessed: 12 November 2024).